Firstly, they compared eryptosis levels and systemic inflammatory markers (such as CRP, IL-6, and IL-1β) in 31 PD patients with acute peritonitis and 34 PD patients with no history of systemic inflammation or peritonitis in the past three months, representing the control group. The gene discussed is CRP; the disease is peritonitis.